---
figid: PMC2578840__nihms69505f8
figlink: /pmc/articles/PMC2578840/figure/F8/
number: Fig. 8
caption: Model of proposed signaling pathway. In mature osteoclasts, TGF-β rapidly
  activates both SMAD and TAK1. TAK1 activation leads to sequential activation of
  MEK1/2, AKT, NIK, and IKKα/β, leading to phosphorylation of IκB. This causes targeted
  degradation of IκB, allowing subsequent NFκB nuclear localization to promote osteoclast
  survival. TGF-β-dependent SMAD2/3 activation and nuclear localization also occurs
  in parallel. NFκB activates transcription of BCLXL and Mcl-1 whereas SMAD2/3 activate
  transcription of Mcl-1.
pmcid: PMC2578840
papertitle: TGF-β Coordinately Activates TAK1/MEK/AKT/NFkB and Smad Pathways to Promote
  Osteoclast Survival.
reftext: Anne Gingery, et al. Exp Cell Res. ;314(15):2725-2738.
pmc_ranked_result_index: '85152'
pathway_score: 0.931713
filename: nihms69505f8.jpg
figtitle: Proposed signaling pathway
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2578840__nihms69505f8.html
  '@type': Dataset
  description: Model of proposed signaling pathway. In mature osteoclasts, TGF-β rapidly
    activates both SMAD and TAK1. TAK1 activation leads to sequential activation of
    MEK1/2, AKT, NIK, and IKKα/β, leading to phosphorylation of IκB. This causes targeted
    degradation of IκB, allowing subsequent NFκB nuclear localization to promote osteoclast
    survival. TGF-β-dependent SMAD2/3 activation and nuclear localization also occurs
    in parallel. NFκB activates transcription of BCLXL and Mcl-1 whereas SMAD2/3 activate
    transcription of Mcl-1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IKBKG
  - CHUK
  - MCL1
  - TGFB3
  - TGFB1
  - SMAD4
  - AKT2
  - IKBKB
  - TGFB2
  - NR2C2
  - SMAD3
  - NFKB2
  - REL
  - SMAD2
  - AKT1
  - MAP2K1
  - MAP2K2
  - RELB
  - NFKB1
  - AKT3
  - RELA
genes:
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: Mcl-1
  symbol: Mcl-1
  source: hgnc_alias_symbol
  hgnc_symbol: MCL1
  entrez: '4170'
- word: TGF-b
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: TGF-b
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: SMAD4
  symbol: SMAD4
  source: hgnc_symbol
  hgnc_symbol: SMAD4
  entrez: '4089'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: TGF-b
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: (TAK1
  symbol: TAK1
  source: hgnc_alias_symbol
  hgnc_symbol: NR2C2
  entrez: '7182'
- word: SMAD2/3
  symbol: SMAD3
  source: hgnc_symbol
  hgnc_symbol: SMAD3
  entrez: '4088'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: SMAD2/3
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
chemicals: []
diseases: []
---
